Ken Griffin acquired 118 Thousand Intellia Therapeutics shares worth $973 Thousand. That's 0.00% of their equity portfolio (2881st largest holding). The first Intellia Therapeutics trade was made in Q3 2017. Since then Ken Griffin bought shares 44 more times and sold shares on 42 occasions. The investor's estimated purchase price is $4.93 Million, resulting in a loss of 80%.